Optimising Ventilation in Preterms With Closed-loop Oxygen Control
Launched by KING'S COLLEGE HOSPITAL NHS TRUST · Aug 25, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special computer program, called 'closed-loop automated oxygen control' (CLAC), can help premature infants breathe better while they are on a ventilator. Many premature babies need help with breathing, and while ventilators can save lives, they can also cause problems for the lungs and other organs. This study aims to see if using the automated system can reduce the time these infants spend on the ventilator compared to when a medical team adjusts the oxygen levels manually. The hope is that CLAC will not only help maintain the right oxygen levels but also allow babies to stop using the ventilator sooner, which could lead to fewer complications.
To participate in this trial, infants must be less than 31 weeks old at birth and need mechanical ventilation within the first 48 hours after birth. Unfortunately, babies born at or after 31 weeks, or those with serious birth defects, cannot join. If eligible, participants can expect to have their oxygen levels monitored closely with this new system to help researchers understand its effectiveness. Overall, this study could provide valuable insights into improving care for premature infants who need respiratory support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm infants less than 31 weeks completed gestation at birth requiring mechanical ventilation and admitted to King's NICU in the first 48 hours after birth
- Exclusion Criteria:
- • Preterm infants above 31 weeks completed gestation or term born infants
- • Infants with major congenital abnormalities
About King's College Hospital Nhs Trust
King's College Hospital NHS Trust is a leading healthcare institution in the United Kingdom, renowned for its commitment to providing high-quality patient care and advancing medical research. With a strong emphasis on clinical excellence, the Trust supports a wide range of clinical trials across various specialties, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. By fostering innovation and collaboration, King's College Hospital NHS Trust aims to enhance treatment options and improve outcomes for patients, while contributing to the global body of medical knowledge through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Anne Greenough, Professor
Principal Investigator
King's College Hospital/ King's College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials